347 related articles for article (PubMed ID: 28806136)
21. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.
Griveau A; Seano G; Shelton SJ; Kupp R; Jahangiri A; Obernier K; Krishnan S; Lindberg OR; Yuen TJ; Tien AC; Sabo JK; Wang N; Chen I; Kloepper J; Larrouquere L; Ghosh M; Tirosh I; Huillard E; Alvarez-Buylla A; Oldham MC; Persson AI; Weiss WA; Batchelor TT; Stemmer-Rachamimov A; Suvà ML; Phillips JJ; Aghi MK; Mehta S; Jain RK; Rowitch DH
Cancer Cell; 2018 May; 33(5):874-889.e7. PubMed ID: 29681511
[TBL] [Abstract][Full Text] [Related]
22. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
[TBL] [Abstract][Full Text] [Related]
23. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
[TBL] [Abstract][Full Text] [Related]
24. An Adult Drosophila Glioma Model for Studying Pathometabolic Pathways of Gliomagenesis.
Chi KC; Tsai WC; Wu CL; Lin TY; Hueng DY
Mol Neurobiol; 2019 Jun; 56(6):4589-4599. PubMed ID: 30357574
[TBL] [Abstract][Full Text] [Related]
25. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
26. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
Phillips JJ; Huillard E; Robinson AE; Ward A; Lum DH; Polley MY; Rosen SD; Rowitch DH; Werb Z
J Clin Invest; 2012 Mar; 122(3):911-22. PubMed ID: 22293178
[TBL] [Abstract][Full Text] [Related]
27. Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting.
Liu H; Weng W; Guo R; Zhou J; Xue J; Zhong S; Cheng J; Zhu MX; Pan SJ; Li Y
Cell Death Differ; 2020 Nov; 27(11):3146-3161. PubMed ID: 32483381
[TBL] [Abstract][Full Text] [Related]
28. Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression.
Huang H; Yu X; Han X; Hao J; Zhao J; Bebek G; Bao S; Prayson RA; Khalil AM; Jankowsky E; Yu JS
Cell Rep; 2021 Jan; 34(1):108522. PubMed ID: 33406417
[TBL] [Abstract][Full Text] [Related]
29. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
[TBL] [Abstract][Full Text] [Related]
32. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.
Otero JJ; Rowitch D; Vandenberg S
J Neurooncol; 2011 Sep; 104(2):423-38. PubMed ID: 21193945
[TBL] [Abstract][Full Text] [Related]
33. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract][Full Text] [Related]
34. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
35. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of OLIG2 transcription factor in brain cancer.
Tsigelny IF; Kouznetsova VL; Lian N; Kesari S
Oncotarget; 2016 Aug; 7(33):53074-53101. PubMed ID: 27447975
[TBL] [Abstract][Full Text] [Related]
37. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.
Zhang L; He X; Liu X; Zhang F; Huang LF; Potter AS; Xu L; Zhou W; Zheng T; Luo Z; Berry KP; Pribnow A; Smith SM; Fuller C; Jones BV; Fouladi M; Drissi R; Yang ZJ; Gustafson WC; Remke M; Pomeroy SL; Girard EJ; Olson JM; Morrissy AS; Vladoiu MC; Zhang J; Tian W; Xin M; Taylor MD; Potter SS; Roussel MF; Weiss WA; Lu QR
Cancer Cell; 2019 Sep; 36(3):302-318.e7. PubMed ID: 31474569
[TBL] [Abstract][Full Text] [Related]
38. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
39. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract][Full Text] [Related]
40. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
